Mina Abedi

Mina Abedi

Auto-generated profile, based on publicly available information

Mina Abedi

Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2020 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
MPMoloud Payab
Moloud Payab
MAMina Abedi
Mina Abedi
NHNajmeh Foroughi Heravani
Najmeh Foroughi Heravani
MHMahdieh Hadavandkhani
Mahdieh Hadavandkhani
MAMaryam Arabi
Maryam Arabi
BABabak Arjmand
Babak Arjmand

1 December 2020 in Cell Regeneration
Verified
Journal Article
Open access
PDF file
MAMina Abedi
Mina Abedi
SASepideh Alavi-Moghadam
Sepideh Alavi-Moghadam
MPMoloud Payab
Moloud Payab
PGParisa Goodarzi
Parisa Goodarzi
FMFereshteh Mohamadi-Jahani
Fereshteh Mohamadi-Jahani
BABabak Arjmand
Babak Arjmand
Systemic sclerosis is a rare chronic autoimmune disease with extensive microvascular injury, damage of endothelial cells, activation of immune responses, and progression of tissue fibrosis in the skin and various internal organs. According to epidemiological data, women’s populations are more susceptible to systemic sclerosis than men. Until now, various therapeutic options are employed to manage the symptoms of the disease. Since stem cell-based treatments have developed as a novel approach to rescue from several autoimmune diseases, it seems that stem cells, especially mesenchymal stem cells as a powerful regenerative tool can also be advantageous for systemic sclerosis treatment via their remarkable properties including immunomodulatory and anti-fibrotic effects. Accordingly, we discuss the contemporary status and future perspectives of mesenchymal stem cell transplantation for systemic sclerosis.

1 December 2019
Verified
Journal Article
Open access
PDF file
BLBagher Larijani
Bagher Larijani
PGParisa Goodarzi
Parisa Goodarzi
MPMoloud Payab
Moloud Payab
SASepideh Alavi-Moghadam
Sepideh Alavi-Moghadam
FRFakher Rahim
Fakher Rahim
BABabak Arjmand
Babak Arjmand
Diabetes with a broad spectrum of complications has become a global epidemic metabolic disorder. Till now, several pharmaceutical and non-pharmaceutical therapeutic approaches were applied for its treatment. Cell-based therapies have become promising methods for diabetes treatment. Better understanding of diabetes pathogenesis and identification of its specific biomarkers along with evaluation of different ...